AbbVie s.r.o. secures contract for Antivirals for Systemic Use - Medicinal products containing the active substance of the Glekaprevir and Pibentasvir

Czechia, Feb. 4 -- Czechia based AbbVie s.r.o. has secured contract from Krajska nemocnice Liberec, a.s. for Antivirals for Systemic Use - Medicinal products containing the active substance of the Glekaprevir and Pibentasvir. The value of the contract is worth 1582507832 CZK.

Published by HT Digital Content Services with permission from Pivotal Sources....